4.6 Review

Dendritic cells and cytokines in immune rejection of cancer

Journal

CYTOKINE & GROWTH FACTOR REVIEWS
Volume 19, Issue 1, Pages 93-107

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2007.10.003

Keywords

dendritic cells; cytokines; immune potentiators; cancer immunity; immunotherapy

Funding

  1. Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom

Ask authors/readers for more resources

Dendritic cells (DCs) play a crucial role in linking innate and adaptive immunity and, thus, in the generation of a protective immune response against both infectious diseases and tumors. The ability of DCs to prime and expand an immune response is regulated by signals acting through soluble mediators, mainly cytokines and chemokines. Understanding how cytokines influence DC functions and orchestrate the interactions of DCs with other immune cells is strictly instrumental to the progress in cancer immunotherapy. Herein, we will illustrate how certain cytokines and immune stimulating molecules can induce and sustain the antitumor immune response by acting on DCs. We will also discuss these cytokine-DC interactions in the light of clinical results in cancer patients. (c) 2007 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available